Local Drug Delivery: New Approaches in Endovascular Therapies

  • Aaron V. Kaplan


The ability to deliver agent directly into the arterial wall holds great promise for the treatment of coronary arterial and peripheral vascular disorders. The initial focus of catheter-based drug delivery has been the delivery of classic pharmaceutical agents in the setting of angioplasty to prevent acute complications and late restenosis. More recently preclinical studies have focused on the delivery of novel agents (e.g., adenoviral vectors) to prevent restenosis and to promote angiogenesis.1


Drug Delivery Balloon Catheter Local Delivery Local Drug Delivery Cutting Balloon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Belle E, et al: Successful percutaneous adenovirus-mediated gene transfer performed during stent implantation, Circulation 94 (suppl 1): 259, 1996.Google Scholar
  2. 2.
    Serruys PW, et al: A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, N Engl J Med 331: 489–495, 1994.PubMedCrossRefGoogle Scholar
  3. 3.
    Fischman DL, et al: A randomized comparison of coronary-stent placement and balloon angio plasty in the treatment of coronary artery disease, N Engl J Med 331: 496–501, 1994.PubMedCrossRefGoogle Scholar
  4. 4.
    Edelman ER, Karnovsky MJ: Contrasting effects of intermittent and continuous administration of heparin in experimental restenosis, Circulation 89: 770–776, 1994.PubMedCrossRefGoogle Scholar
  5. 5.
    TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) trial, N Engl J Med 320: 618–627, 1989.CrossRefGoogle Scholar
  6. 6.
    Global Use of Strategies to Open Occluded Investigators: randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syn dromes, Circulation 90:1631–1637,1994.Google Scholar
  7. 7.
    Ellis SG, et al: Coronary morphologic and keep our clinical determinants of procedural outcome with angioplasty for multivessel coronary disease, Circulation 82: 1193–1202, 1990.PubMedCrossRefGoogle Scholar
  8. 8.
    Lincoff AM, et al: Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery [abstract], J Am Coll Cardiol 23: 18A, 1994.Google Scholar
  9. 9.
    Wolinsky H, Thung SN: Use of a perforated trial balloon catheter to deliver concentrated heparin into the wall of the normal canine artery, J Am Coll Cardiol 15: 475–481, 1990.PubMedCrossRefGoogle Scholar
  10. 10.
    Leung W-H, et al: Local delivery of an antithrombin agent by an infusion balloon catheter reduces platelet deposition at the site of balloon angioplasty, Coronary Artery Dis 2: 699–706, 1991.Google Scholar
  11. 11.
    Kaplan AV, et al: Local infusion of the thrombin reduces platelet thrombus formation at the site of angioplasty [abstract], Circulation 84 (suppl II): 727, 1991.Google Scholar
  12. 12.
    Shi Y, et al: Transcatheter delivery of c-myc antineointimal formation in porcine model of coronary artery balloon injury, Circulation 90: 944–951, 1994.PubMedCrossRefGoogle Scholar
  13. 13.
    Muller DWM, et al: Intramural methotrexate therapy for the prevention of neointimal thick intramural ening after balloon angioplasty, J Am Coll Cardiol 20: 460–466, 1992.PubMedCrossRefGoogle Scholar
  14. 14.
    Gimple LW, et al: Effect of “in situ” heparin delivery by a porous balloon catheter on restenosis following balloon angioplasty [abstract], J Am Coll Cardiol 19: 169A, 1992.Google Scholar
  15. 15.
    Santolan EC, et al: Use of a porous infusion balloon in swine coronary arteries: low pressure minimizes arterial damage [abstract], Circulation 84 (suppl II): 591, 1991.Google Scholar
  16. 16.
    Rasheed Q, et al: Local intramural drug delivery using an infusion balloon following angioplasty in normal and atherosclerotic vessels, Cathet Cardiovasc Diagn 31: 240–245, 1994.PubMedCrossRefGoogle Scholar
  17. 17.
    Plante S, et al: Porous balloon catheters for local delivery: assessment of vascular damage in a rabbit iliac angioplasty model,JAm Coll Cardiol 24: 820–824, 1994.Google Scholar
  18. 18.
    Stadius ML, Collins C, Kernoff R: Local infusion balloon angioplasty to obviate restenosis compared with conventional balloon angioplasty in an experimental model of atherosclerosis, Heart J 126: 47–56, 1993.CrossRefGoogle Scholar
  19. 19.
    Gellman J, et al: Evaluation of a local infusion catheter for simultaneous balloon angioplasty and vessel wall infusion [abstract], Circ Res 38: 492A, 1990.Google Scholar
  20. 20.
    Wolinsky H: Local delivery: let’s keep our eyes on the wall, J Am Coll Cardiol 24: 825–827, 1994.PubMedCrossRefGoogle Scholar
  21. 21.
    Lincoff AM, et al: Efficiency of solute transfer by a microporous balloon catheter in the porcine coronary model of arterial injury [abstract], J Am Coll Cardiol 23: 18A, 1994.Google Scholar
  22. 22.
    Wilensky RL, et al: The biostent trial: a randomized, double-blind, prospective, multi-center evaluating the safety and tolerability of locally delivered cytochlasin B in prophylaxis of angioplasty restenosis, Circulation 96 (suppl I): 650, 1997.Google Scholar
  23. 23.
    Bassand JP, et al: Update: interim results of the IMPRESS randomized trial. In: Proceedings of the local drug delivery meeting and cardiovascular course on radiation and molecular strategies, February 1998, p 58.Google Scholar
  24. 24.
    Hong MK, et al: A dual-purpose angioplasty drug infusion catheter for the treatment of intragraft thrombus, Cathet Cardiovasc Diagn 32: 193–195, 1994.PubMedCrossRefGoogle Scholar
  25. 25.
    Cumberland DC, et al: Initial clinical experience of local drug delivery via a porous balloon during percutaneous coronary angioplasty [abstract], JAm Coll Cardiol 23: 891A, 1994.Google Scholar
  26. 26.
    Deutsch E, et al: Favorable impact of intramural low molecular weight heparin delivered at the time of coronary stent deployment on late loss in de novo lesions, Circulation 96 (suppl I): 650, 1997.Google Scholar
  27. 27.
    Kutryk MJB, et al: Feasibility of the local delivery of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: acute results of the Thoraxcentra ITALICS trial, Eur Heart J 18: 507, 1997.CrossRefGoogle Scholar
  28. 28.
    Kaplan AV: Infusion sleeve catheter, Semin Intervent Cardiol 1: 36–38, 1996.Google Scholar
  29. 29.
    Kaplan AV, et al: Intramural delivery of marker agent in ex vivo and in vivo models using a novel drug delivery sleeve [abstract], J Am Coll Cardiol 23: 187A, 1994.Google Scholar
  30. 30.
    Kaplan AV, et al: Heparin delivery at the site of angioplasty with a novel drug delivery sleeve: initial clinical series [abstract], J Am Coll Cardiol 25: 286a, 1995.Google Scholar
  31. 31.
    Bartorelli AL, et al: Local heparin delivery prior to coronary stent implantation: acute and six-month clinical and angiographic results, Cathet Cardiovasc Diagn 42: 1–8, 1997.CrossRefGoogle Scholar
  32. 32.
    Wilensky R, et al: The heparin infusion prior to stenting trial (HIPS): safety data and initial results of a randomized, prospective trial evaluating the efficacy of locally delivered heparin in reducing in-stent restenosis [abstract], Circulation 96 (suppl I): 710, 1997.Google Scholar
  33. 33.
    Esente P, et al: Acute and subactue stent thrombosis treated with local heparin therapy, Submitted.Google Scholar
  34. 34.
    Thomas CN, et al: Local delivery of heparin with a PTCA infusion balloon inhibits platelet-dependent thrombosis [abstract], J Am Coll Cardiol 23: 4A, 1994.Google Scholar
  35. 35.
    Hong MK, et al: A new PTCA balloon catheter, with intramural channels for local delivery of drugs at low pressure [abstract], Circulation 86 (suppl I): 380, 1992.Google Scholar
  36. 36.
    Fram DB, et al: Local heparin delivery in porcine coronary arteries with the Dispatch Catheter: delivery, washout and effect on platelet deposition following balloon angioplasty [abstract], Circulation 90 (suppl I): 493, 1994.Google Scholar
  37. 37.
    Mitchell JF, et al: Enhanced intracoronary thrombolysis using the Dispatch Catheter [abstract], Circulation 90 (suppl I): 493, 1994.Google Scholar
  38. 38.
    McKay RG, et al: Treatment of intracoronary thrombus with local urokinase infusion using a new site-specific drug delivery system: the Dispatch Catheter, Cathet Cardiovasc Diagn 33: 181–188, 1994.PubMedCrossRefGoogle Scholar
  39. 39.
    Fram DB, et al: Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion, J Am Coll Cardiol 23: 1570–1577, 1994.PubMedCrossRefGoogle Scholar
  40. 40.
    Riessen R, et al: Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon, Hum Gene Ther 4: 749–758, 1993.PubMedCrossRefGoogle Scholar
  41. 41.
    Riessen R, Isner JM: Prospects for site-specific delivery of pharmacologic and molecular therapies, J Am Coll Cardiol 23: 1234–1244, 1994.PubMedCrossRefGoogle Scholar
  42. 42.
    Nunes GL, et al: Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis, J Am Coll Cardiol 23: 1578–1583, 1994.PubMedCrossRefGoogle Scholar
  43. 43.
    Mitchell JF, et al: Local, intracoronary thrombolysis using urokinase-coated hydrogel balloons [abstract], Circulation 90 (suppl I): 493, 1994.Google Scholar
  44. 44.
    Azrin MA, et al: Local delivery of heparin on hydrogel-coated balloons decreases vessel wall cellular proliferation following balloon angioplasty [abstract], Circulation 88 (suppl I): 310, 1993.Google Scholar
  45. 45.
    Welsh RG, et al: lontophoretic drug delivery system, Semin Intervent Cardiol 1:40–42,1996.Google Scholar
  46. 46.
    Fernando-Ortiz A, et al: A new approach for local intravascular drug delivery: iontophoretic balloon, Circulation 89: 1518–1522, 1994.CrossRefGoogle Scholar
  47. 47.
    Barath P, et al: Nipple balloon catheter, Semin Intervent Cardiol 1: 43, 1996.Google Scholar
  48. 48.
    Reimers B, et al: Persistent high restenosis after local delivery of long acting steroids prior to coronary stent implantation, Circulation 96 (suppl I): 710, 1997.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Aaron V. Kaplan

There are no affiliations available

Personalised recommendations